SUPPRESSIVE EFFECT OF L-DOPA ON DOPAMINE CELLS REMAINING IN THE VENTRAL TEGMENTAL AREA OF RATS PREVIOUSLY EXPOSED TO THE NEUROTOXIN 6-HYDROXYDOPAMINE

被引:130
作者
BLUNT, SB
JENNER, P
MARSDEN, CD
机构
[1] KINGS COLL, DIV BIOMED SCI,PHARMACOL GRP,PARKINSONS DIS SOC, EXPTL RES LABS,MANRESA RD, LONDON SW3, ENGLAND
[2] UNIV LONDON, NATL HOSP, INST NEUROL, DEPT CLIN NEUROL, LONDON, ENGLAND
关键词
L-DOPA; NEUROTOXICITY; VENTRAL TEGMENTAL AREA (VTA); PARKINSONS DISEASE;
D O I
10.1002/mds.870080202
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Ever since the introduction of levo-3,4-dihydroxyphenylalanine (L-dopa) for the treatment of Parkinson's disease, there has been concern that it might accelerate the degeneration of dopamine neurones. Using rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the medial forebrain bundle (MFB), we have studied the effect of chronic L-dopa treatment on the survival of dopamine cells which remain in the ventral tegmental area (VTA) ipsilateral to a 6-OHDA lesion. Following lesion surgery, rats were treated with L-dopa and carbidopa administered in the drinking water for 27 weeks. At the end of the treatment period, the number of dopamine cells remaining in each of the lesioned and intact substantia nigra (SN) and VTA were assessed, using tyrosine hydroxylase immunohistochemistry. ChroniC L-dopa treatment resulted in an apparent reduction in the number of dopamine neurones remaining in the VTA ipsilateral to the lesion, whereas it had no effect on the number of dopamine cells remaining in the intact SN and VTA. This finding suggests a possible suppressive effect in vivo Of L-dopa on dopamine cells in the midbrain of adult animals that have been previously exposed to 6-OHDA.
引用
收藏
页码:129 / 133
页数:5
相关论文
共 23 条
[1]
DOES LEVODOPA AGGRAVATE PARKINSONS-DISEASE [J].
BLIN, J ;
BONNET, AM ;
AGID, Y .
NEUROLOGY, 1988, 38 (09) :1410-1416
[2]
THE EFFECT OF L-DOPA AND CARBIDOPA TREATMENT ON THE SURVIVAL OF RAT FETAL DOPAMINE GRAFTS ASSESSED BY TYROSINE-HYDROXYLASE IMMUNOHISTOCHEMISTRY AND [H-3] MAZINDOL AUTORADIOGRAPHY [J].
BLUNT, SB ;
JENNER, P ;
MARSDEN, CD .
NEUROSCIENCE, 1991, 43 (01) :95-110
[3]
COHEN G, 1986, ADV NEUROL, V45, P119
[4]
DEXTER D, 1986, LANCET, V2, P639
[5]
GRAHAM DG, 1978, MOL PHARMACOL, V14, P644
[6]
OXIDANTS AND THE CENTRAL-NERVOUS-SYSTEM - SOME FUNDAMENTAL QUESTIONS - IS OXIDANT DAMAGE RELEVANT TO PARKINSONS-DISEASE, ALZHEIMERS-DISEASE, TRAUMATIC INJURY OR STROKE [J].
HALLIWELL, B .
ACTA NEUROLOGICA SCANDINAVICA, 1989, 80 :23-33
[7]
DOPA AND AMINO-ACID LEVELS IN PLASMA AND CEREBROSPINAL-FLUID OF PATIENTS WITH PARKINSONS-DISEASE BEFORE AND DURING TREATMENT WITH L-DOPA [J].
HARE, TA ;
BEASLEY, BL ;
CHAMBERS, RA ;
BOEHME, DH ;
VOGEL, WH .
CLINICA CHIMICA ACTA, 1973, 45 (03) :273-280
[8]
LONG-TERM ADMINISTRATION OF L-DOPA DOES NOT DAMAGE DOPAMINERGIC-NEURONS IN THE MOUSE [J].
HEFTI, F ;
MELAMED, E ;
BHAWAN, J ;
WURTMAN, RJ .
NEUROLOGY, 1981, 31 (09) :1194-1195
[9]
MELANIZED DOPAMINERGIC-NEURONS ARE DIFFERENTIALLY SUSCEPTIBLE TO DEGENERATION IN PARKINSONS-DISEASE [J].
HIRSCH, E ;
GRAYBIEL, AM ;
AGID, YA .
NATURE, 1988, 334 (6180) :345-348
[10]
DECREASED TYROSINE-HYDROXYLASE MESSENGER-RNA IN THE SURVIVING DOPAMINE NEURONS OF THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE - AN INSITU HYBRIDIZATION STUDY [J].
JAVOYAGID, F ;
HIRSCH, EC ;
DUMAS, S ;
DUYCKAERTS, C ;
MALLET, J ;
AGID, Y .
NEUROSCIENCE, 1990, 38 (01) :245-253